In Baton Rouge, where schoolchildren are learning the old lessons of balanced meals and daily movement, a physician has drawn attention to a newer chapter in the long effort against childhood weight. GLP-1 medications, first embraced by adults, are now being prescribed to a narrow group of children for whom diet and exercise have not been enough. The question she raises is less about willpower than about biology, and about who will be able to afford the answer.
Doctors Begin Prescribing GLP-1 Weight-Loss Drugs to Some Children
"It's not a miracle drug — it's a tool."
Mark
Why does this story matter? GLP-1 drugs have been in the news for adults for a while.
Mimi
Because the audience is changing. Dr. Rhea Rogers says some children are now being prescribed these drugs when diet and exercise haven't worked.
Mark
What's her reasoning?
Mimi
She says move more and eat less isn't always enough, because of genetics, and that at higher weights it becomes a hormonal dysregulation. She says the drugs quiet what she calls food noise.
Luke
I'd note that's one physician's account, in a short segment. There are no trial results, no data on how many children are prescribed these, and nothing on long-term effects.
Mark
Who actually qualifies?
Mimi
Experts cite a BMI at or above the 95th percentile with lifestyle changes having failed. For diabetes patients, the age can be 10 and up.
Luke
Worth being careful there. The 10-and-up figure applies to diabetes patients, not to weight loss generally. The piece doesn't give a weight-loss age threshold.
Mark
And the cost?
Mimi
It's a barrier for many families. If you can't afford it, the option is balanced meals and a healthy lifestyle.
Luke
Which means access, not just medical judgment, may decide who gets treated. The report doesn't say what insurance covers, so that remains unknown.
El Pulso
- A physician says GLP-1 weight-loss drugs are now reaching some children whose lifestyle changes have stalled, pushing a medical tool into a space once governed by habit.
- Experts point to a BMI at or above the 95th percentile and documented failure of lifestyle efforts as the threshold, with diabetes patients qualifying as young as 10.
- Cost is the hard edge of the story: for many families the medication sits out of reach, leaving classroom-style healthy living as the only path.
- The report offers no count of children on these drugs and no long-term outcome data, so the reach and results remain uncertain.
In Baton Rouge, where schoolchildren are learning the old lessons of balanced meals and daily movement, a physician has drawn attention to a newer chapter in the long effort against childhood weight. GLP-1 medications, first embraced by adults, are now being prescribed to a narrow group of children for whom diet and exercise have not been enough. The question she raises is less about willpower than about biology, and about who will be able to afford the answer.
At Magnolia Woods Elementary in Baton Rouge, students are learning about healthy eating and exercise as part of a statewide Louisiana effort to lower obesity rates. For many children, that teaching is enough. For some, one physician says, it is not.
Dr. Rhea Rogers, a board-certified physician, says GLP-1 weight-loss drugs, popular among adults, are now being prescribed to some children. Her argument starts with the limits of standard advice: genetics play a role, and once weight climbs high enough, she says, the problem becomes hormonal rather than simply a matter of habits.
She describes these drugs as helpful in quieting the constant pull toward eating, which she calls food noise, and as anti-inflammatory. Some children, she says, simply need more help to counter that imbalance. Experts cite a body mass index at or above the 95th percentile and failed lifestyle changes as the ideal criteria for weight-loss use, while diabetes patients can start as young as 10.
Rogers is careful to frame the drugs as a tool, not a miracle, and insists the whole child must be treated, not just the number on the scale.
Cost, however, looms large. For families who cannot afford the medication, or who choose not to use it, the path forward remains the one taught in Louisiana classrooms: balanced meals and an active life. The report does not say how many children are receiving these drugs, but it makes clear that cost will likely decide who gets access.
At Magnolia Woods Elementary in Baton Rouge, students are being taught about healthy eating and exercise. The lessons are part of a statewide push in Louisiana to bring down obesity rates. For many children, that kind of education is the whole of the answer. For some, according to one physician, it is not.
Dr. Rhea Rogers, a board-certified physician and host of Aging Untold, says GLP-1 weight-loss drugs, which have become popular among adults, are now being prescribed to some children. She described the practice in a segment reported out of Baton Rouge.
Rogers' argument starts with the limits of the standard advice. Telling a child to move more and eat less, she said, is sometimes not enough, because genetics play a part. She also pointed to what happens when a child's weight climbs too high: at that point, she said, the problem becomes a hormonal dysregulation, not simply a matter of habits.
That is where she sees a role for what are called GLP-1 agonists. Rogers described them as huge in quieting what she called food noise and food chatter, the constant pull toward eating. She also described the drugs as anti-inflammatory. Some people, she said, simply need a little more help because of that hormonal imbalance.
The report offers some guidance on who might qualify. For patients with diabetes, the age requirement can be as low as 10. For weight loss, experts say the ideal candidate has a body mass index at or above the 95th percentile and has not succeeded with lifestyle changes alone. That group includes patients who have developed hormone problems requiring medical intervention.
Rogers was careful to put the drugs in perspective. She called them not a miracle drug but a tool, and said the whole situation has to be treated, not just the number on the scale.
Then there is the matter of money. The price of GLP-1 drugs remains a barrier for many families. For patients who cannot afford the medication, or who choose not to take any, the option for now is the one already being taught in Louisiana classrooms: well-balanced meals and a healthy lifestyle.
The report does not say how many children are currently receiving these drugs, nor does it name specific products or describe long-term outcomes. What it does make clear is that the conversation about childhood obesity now includes medication for a narrow group, and that cost will likely determine who actually has access.
Citas Notables
It's not a miracle drug — it's a tool, and so you have to treat the whole entire scenario.— Dr. Rhea Rogers, board-certified physician and Aging Untold host
Quieres la nota completa?
Lee el original en WIS10 ↗
Health & Medicine